Yi‐Hung Lin

Metabolic dysfunction-associated steatotic liver disease in adults

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

A People-Centered Decentralized Outreach Model Toward HCV Micro-Elimination in Hyperendemic Areas: COMPACT Study in SARS Co-V2 Pandemic

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients